In breast cancer cells, FADS1/2 have also been linked to inflammation via their production of arachidonic acid (54), suggesting that their suppression in MM-MSCs may be linked to an anti-inflammatory response linked to increased cytokine signaling (55). Here, FADS1 is linked to breast cancer.